<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Colección :</title>
  <link rel="alternate" href="https://hdl.handle.net/11000/30622" />
  <subtitle />
  <id>https://hdl.handle.net/11000/30622</id>
  <updated>2026-04-29T15:25:38Z</updated>
  <dc:date>2026-04-29T15:25:38Z</dc:date>
  <entry>
    <title>Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39815" />
    <author>
      <name>Ortega del Campo, Sergio</name>
    </author>
    <author>
      <name>Fernández Ballester, Gregorio Joaquín</name>
    </author>
    <author>
      <name>Blanes Mira, Clara</name>
    </author>
    <author>
      <name>Guirado Osorio, Víctor</name>
    </author>
    <author>
      <name>Díaz Martínez, Luis</name>
    </author>
    <author>
      <name>de Ávila, Ana Isabel</name>
    </author>
    <author>
      <name>Soria, María Eugenia</name>
    </author>
    <author>
      <name>Martínez-González, Brenda</name>
    </author>
    <author>
      <name>Villena González, Francisco José</name>
    </author>
    <author>
      <name>Gómez-Maldonado, Josefa</name>
    </author>
    <author>
      <name>Viciana Ramos, María Isabel</name>
    </author>
    <author>
      <name>Clavijo Frutos, Encarnación</name>
    </author>
    <author>
      <name>Santos González, Jesús L.</name>
    </author>
    <author>
      <name>Bastolla, Hugo</name>
    </author>
    <author>
      <name>Perales, Celia</name>
    </author>
    <author>
      <name>Domingo, Esteban</name>
    </author>
    <author>
      <name>Viguera, Enrique</name>
    </author>
    <author>
      <name>Fernández Escamilla, Ana María</name>
    </author>
    <author>
      <name>Grande Pérez, Ana</name>
    </author>
    <id>https://hdl.handle.net/11000/39815</id>
    <updated>2026-04-29T08:09:07Z</updated>
    <published>2026-04-29T08:09:06Z</published>
    <summary type="text">Título : Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication
Autor : Ortega del Campo, Sergio; Fernández Ballester, Gregorio Joaquín; Blanes Mira, Clara; Guirado Osorio, Víctor; Díaz Martínez, Luis; de Ávila, Ana Isabel; Soria, María Eugenia; Martínez-González, Brenda; Villena González, Francisco José; Gómez-Maldonado, Josefa; Viciana Ramos, María Isabel; Clavijo Frutos, Encarnación; Santos González, Jesús L.; Bastolla, Hugo; Perales, Celia; Domingo, Esteban; Viguera, Enrique; Fernández Escamilla, Ana María; Grande Pérez, Ana
Resumen : The limited durability of vaccine protection and the rapid emergence of SARS-CoV-2 variants highlight the need for antiviral strategies that extend beyond vaccination and conventional small-molecule inhibitors. Here, we explored a dual approach combining structure-guided peptides predicted to interfere with the viral replication complex with lethal mutagenesis to limit SARS-CoV-2 replication. Using the crystallographic interfaces of nsp10 with nsp14 and nsp16, we designed short inhibitory peptides predicted to interact with the viral proofreading and RNA-capping machinery. In parallel, the mutagenic analog 5-fluorouracil was evaluated to determine its effecteffecteffecton SARS-CoV-2 in Vero E6 cells. Peptides P1 and P6 exhibited potent antiviral activity with minimal cytotoxicity, whereas 5-FU reduced specific infectivity without impairing genome replication. Combined treatment with 5-FU and peptide P1 resulted in &gt;104-fold reduction in infectious virus, achieving near-complete loss of infectivity at non-cytotoxic concentrations. Next-generation sequencing revealed that dual treatment increased mutation frequency, altered mutant spectra, and decreased genome stability, consistent with progression toward error catastrophe. Principal component analysis confirmed that combined treatment generated mutant spectra distinct from either monotherapy. These findings are consistent with a dual antiviral strategy in which structure-guided peptides designed to interact with components of the SARS-CoV-2 replication complex act in combination with lethal mutagenesis to produce a synergistic interaction between these two complementary processes. This integrated approach suggests a potential broad-spectrum antiviral strategy with applicability to other coronaviruses.</summary>
    <dc:date>2026-04-29T08:09:06Z</dc:date>
  </entry>
  <entry>
    <title>Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39585" />
    <author>
      <name>Madruga, Enrique</name>
    </author>
    <author>
      <name>García-Rubia, Alfonso</name>
    </author>
    <author>
      <name>Sánchez-Núñez, Carlos</name>
    </author>
    <author>
      <name>Martínez-González, Loreto</name>
    </author>
    <author>
      <name>Fernández-Escamilla, Ana María</name>
    </author>
    <author>
      <name>Lastres-Becker, Isabel</name>
    </author>
    <author>
      <name>Gil, Carmen</name>
    </author>
    <author>
      <name>Martínez, Ana</name>
    </author>
    <id>https://hdl.handle.net/11000/39585</id>
    <updated>2026-03-26T02:06:57Z</updated>
    <published>2026-03-25T13:47:05Z</published>
    <summary type="text">Título : Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases
Autor : Madruga, Enrique; García-Rubia, Alfonso; Sánchez-Núñez, Carlos; Martínez-González, Loreto; Fernández-Escamilla, Ana María; Lastres-Becker, Isabel; Gil, Carmen; Martínez, Ana
Resumen : A major challenge in modern medicine is developing&#xD;
new therapies for aging-related diseases such as neurodegenerative&#xD;
disorders, whose prevalence increases with longer life expectancy.&#xD;
Although kinase inhibitors have achieved clinical success, their&#xD;
development for central nervous system (CNS) disorders remains&#xD;
limited due to the complexity of kinase networks and poor blood−&#xD;
brain barrier (BBB) permeability. Serum/glucocorticoid-regulated&#xD;
kinase 1 (SGK1) participates in multiple signaling pathways but&#xD;
remains an underexplored target in neurodegeneration. Following a&#xD;
mixed ligand- and structure-based virtual screening, we have&#xD;
previously identified a brain-penetrant SGK1 inhibitor. A medicinal&#xD;
chemistry program based on hit expansion and optimization for&#xD;
BBB permeability reported here has generated a new family of&#xD;
SGK1 inhibitors as chemical probes that enable the investigation of SGK1’s role in neurological disorders and serve as promising&#xD;
starting points for drug development. These findings highlight SGK1 as a potential therapeutic target for neurodegenerative diseases,&#xD;
such as Alzheimer’s disease.</summary>
    <dc:date>2026-03-25T13:47:05Z</dc:date>
  </entry>
  <entry>
    <title>Artificial intelligence and first-principle methods in protein redesign: A marriage of convenience?</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39409" />
    <author>
      <name>Cianferoni, Damiano</name>
    </author>
    <author>
      <name>Vizarraga, David</name>
    </author>
    <author>
      <name>Fernández-Escamilla, Ana Mª</name>
    </author>
    <author>
      <name>Fita, Ignacio</name>
    </author>
    <author>
      <name>Hamdani, Rahma</name>
    </author>
    <author>
      <name>Reche, Raul</name>
    </author>
    <author>
      <name>Delgado, Javier</name>
    </author>
    <author>
      <name>Serrano, Luis</name>
    </author>
    <id>https://hdl.handle.net/11000/39409</id>
    <updated>2026-02-24T02:08:47Z</updated>
    <published>2026-02-23T17:35:32Z</published>
    <summary type="text">Título : Artificial intelligence and first-principle methods in protein redesign: A marriage of convenience?
Autor : Cianferoni, Damiano; Vizarraga, David; Fernández-Escamilla, Ana Mª; Fita, Ignacio; Hamdani, Rahma; Reche, Raul; Delgado, Javier; Serrano, Luis
Resumen : Since AlphaFold2’s rise, many deep learning methods for protein design&#xD;
have emerged. Here, we validate widely used and recognized tools, compare&#xD;
them with first-principle methods, and explore their combinations,&#xD;
focusing on their effectiveness in protein redesign and potential for therapeutic&#xD;
repurposing. We address two challenges: evaluating tools and combinations&#xD;
ability to detect the effects of multiple concurrent mutations in&#xD;
protein variants, and leveraging large-scale datasets to compare modelingfree&#xD;
methods, namely force fields, which handle point mutations well with&#xD;
limited backbone rearrangement, and inverse folding tools, which excel at&#xD;
native sequence recovery but may struggle with non-natural proteins.&#xD;
Debuting TriCombine, a tool that identifies residue triangles in input structures,&#xD;
matches them to a structural database, and scores mutants based on&#xD;
substitution frequencies, we shortlisted candidates, modeled them with&#xD;
FoldX, and generated 16 SH3 mutants carrying up to 9 concurrent substitutions.&#xD;
The dataset was expanded to include 36 mutants and 11 crystal structures&#xD;
(7 newly solved), along with a parallel set of multiple non-concurrent&#xD;
mutants from three additional proteins. For broader validation, we analyzed&#xD;
160,000 four-site GB1 mutants and 163,555 (single and double) variants&#xD;
across 179 natural and de novo domains. We show that combining AIbased&#xD;
modeling tools with force field scoring functions yields the most reliable&#xD;
results. Inverse folding tools perform very well but lose accuracy on&#xD;
less-represented proteins. First-principle force fields like FoldX remain the&#xD;
most accurate for point mutations. All methods perform worse when applied&#xD;
to unsolved de novo models, underscoring the need for hybrid strategies in&#xD;
robust protein design.</summary>
    <dc:date>2026-02-23T17:35:32Z</dc:date>
  </entry>
  <entry>
    <title>Engineering Biological Approaches for Detection of Toxic Compounds: A New Microbial Biosensor Based on the Pseudomonas putida TtgR Repressor</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39408" />
    <author>
      <name>Espinosa-Urgel, Manuel</name>
    </author>
    <author>
      <name>Serrano, Luis</name>
    </author>
    <author>
      <name>Ramos, Juan Luis</name>
    </author>
    <author>
      <name>Fernández-Escamilla, Ana Mª</name>
    </author>
    <id>https://hdl.handle.net/11000/39408</id>
    <updated>2026-02-24T02:08:46Z</updated>
    <published>2026-02-23T17:14:17Z</published>
    <summary type="text">Título : Engineering Biological Approaches for Detection of Toxic Compounds: A New Microbial Biosensor Based on the Pseudomonas putida TtgR Repressor
Autor : Espinosa-Urgel, Manuel; Serrano, Luis; Ramos, Juan Luis; Fernández-Escamilla, Ana Mª
Resumen : Environmental contamination by toxic organic compounds and antimicrobials is one of the causes for the recent surge of multidrug-resistant pathogenic bacteria. Monitoring contamination is therefore the first step in containment of antimicrobial resistance and requires the development of simple, sensitive, and quantitative tools that detect a broad spectrum of toxic compounds. In this study, we have engineered a new microbial biosensor based on the ttgR-regulated promoter that controls expression of the TtgABC extrusion efflux pump of Pseudomonas putida, coupled to a gfp reporter. The system was introduced in P. putida DOT-T1E, a strain characterized by its ability to survive in the presence of high concentrations of diverse toxic organic compounds. This whole-cell biosensor is capable to detect a wide range of structurally diverse antibiotics, as well as compounds such as toluene or flavonoids.</summary>
    <dc:date>2026-02-23T17:14:17Z</dc:date>
  </entry>
  <entry>
    <title>Engineering Biological Approaches for Detection of Toxic Compounds: A New Microbial Biosensor Based on the Pseudomonas putida TtgR Repressor</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39333" />
    <author>
      <name>Espinosa-Urgel, Manuel</name>
    </author>
    <author>
      <name>Serrano, Luis</name>
    </author>
    <author>
      <name>Ramos, Juan Luis</name>
    </author>
    <author>
      <name>Fernández-Escamilla, Ana Mª</name>
    </author>
    <id>https://hdl.handle.net/11000/39333</id>
    <updated>2026-02-17T02:08:18Z</updated>
    <published>2026-02-16T17:03:17Z</published>
    <summary type="text">Título : Engineering Biological Approaches for Detection of Toxic Compounds: A New Microbial Biosensor Based on the Pseudomonas putida TtgR Repressor
Autor : Espinosa-Urgel, Manuel; Serrano, Luis; Ramos, Juan Luis; Fernández-Escamilla, Ana Mª
Resumen : Environmental contamination by toxic organic&#xD;
compounds and antimicrobials is one of the causes for the&#xD;
recent surge of multidrug-resistant pathogenic bacteria.&#xD;
Monitoring contamination is therefore the first step in&#xD;
containment of antimicrobial resistance and requires the&#xD;
development of simple, sensitive, and quantitative tools&#xD;
that detect a broad spectrum of toxic compounds. In this&#xD;
study, we have engineered a new microbial biosensor based&#xD;
on the ttgR-regulated promoter that controls expression of&#xD;
the TtgABC extrusion efflux pump of Pseudomonas putida,&#xD;
coupled to a gfp reporter. The system was introduced in&#xD;
P. putida DOT-T1E, a strain characterized by its ability to&#xD;
survive in the presence of high concentrations of diverse&#xD;
toxic organic compounds. This whole-cell biosensor is&#xD;
capable to detect a wide range of structurally diverse antibiotics,&#xD;
as well as compounds such as toluene or&#xD;
flavonoids.</summary>
    <dc:date>2026-02-16T17:03:17Z</dc:date>
  </entry>
  <entry>
    <title>Novel BRAFI599Ins Mutation Identified in a Follicular Variant of Papillary Thyroid Carcinoma: A Molecular Modeling Approach</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39332" />
    <author>
      <name>Cañadas-Garre, Marisa</name>
    </author>
    <author>
      <name>Fernández-Escamilla, Ana Mª</name>
    </author>
    <author>
      <name>Fernández-Ballester, Gregorio</name>
    </author>
    <author>
      <name>Becerra-Massare, Patricia</name>
    </author>
    <author>
      <name>García-Calvente, Carlos</name>
    </author>
    <author>
      <name>Ramos, Juan Luis</name>
    </author>
    <author>
      <name>Llamas-Elvira, José Manuel</name>
    </author>
    <id>https://hdl.handle.net/11000/39332</id>
    <updated>2026-02-17T02:08:17Z</updated>
    <published>2026-02-16T16:53:51Z</published>
    <summary type="text">Título : Novel BRAFI599Ins Mutation Identified in a Follicular Variant of Papillary Thyroid Carcinoma: A Molecular Modeling Approach
Autor : Cañadas-Garre, Marisa; Fernández-Escamilla, Ana Mª; Fernández-Ballester, Gregorio; Becerra-Massare, Patricia; García-Calvente, Carlos; Ramos, Juan Luis; Llamas-Elvira, José Manuel
Resumen : Objective: BRAF mutations are the most common&#xD;
genetic alteration found in papillary thyroid carcinoma&#xD;
(PTC). Approximately, 90% correspond to BRAFV600E,&#xD;
although other less common BRAF mutations have been&#xD;
described. The aim of this study was to describe a new&#xD;
mutation on BRAF gene discovered on the previous thyroid&#xD;
cytology of a patient diagnosed with a follicular variant of&#xD;
PTC (FV-PTC).&#xD;
Methods: The mutation was identified by independent&#xD;
cloning of the 2 alleles and direct sequencing in the previous&#xD;
cytology and tumor tissue samples from a patient diagnosed&#xD;
with FV-PTC. To elucidate the effect of the mutation&#xD;
on the structure and hence on the activating mechanism&#xD;
of the protein, the structures of BRAFI599Ins, BRAFT599Ins,&#xD;
BRAFV599Ins and BRAFV600E were modeled by using&#xD;
the reconstructed wild-type BRAF (BRAFWT) crystal&#xD;
structure.&#xD;
Results: The novel mutation in BRAF consisted in the&#xD;
in-frame insertion of 3 nucleotides (TAA) after nucleotide&#xD;
1795, resulting in the incorporation of an extra isoleucine&#xD;
residue at position 599 (BRAFI599Ins) of the protein.&#xD;
The structural comparison of BRAFI599Ins, BRAFT599Ins,&#xD;
BRAFV599Ins with BRAFWT, and BRAFV600E models&#xD;
revealed that the overall shape of the kinase was conserved&#xD;
in the protein produced by this novel mutation, except for&#xD;
the displacement of the activation loop (A-loop), as a direct&#xD;
consequence of the increase in loop size, and the exposition&#xD;
of 1 of the 2 residues involved in BRAF activation&#xD;
(T599), probably facilitating its phosphorylation.&#xD;
Conclusion: BRAFI599Ins mutation constitutes a new&#xD;
BRAF mutation affecting the length of the A-loop, which&#xD;
most likely facilitates BRAF activation by altering the&#xD;
A-loop conformation.</summary>
    <dc:date>2026-02-16T16:53:51Z</dc:date>
  </entry>
  <entry>
    <title>8.3 Molecular Responses to Solvent Stress: Strategies for Living in Unpalatable Substrates</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39315" />
    <author>
      <name>Ramos, Juan Luis</name>
    </author>
    <author>
      <name>Daniels, Craig</name>
    </author>
    <author>
      <name>Krell, Tino</name>
    </author>
    <author>
      <name>Duque, Estrella</name>
    </author>
    <author>
      <name>Godoy, Patricia</name>
    </author>
    <author>
      <name>de la Torre, Jesús</name>
    </author>
    <author>
      <name>Fernández-Escamilla, Ana Mª</name>
    </author>
    <author>
      <name>Daddaoua, Abdelali</name>
    </author>
    <author>
      <name>Navarro-Avilés, Gloria</name>
    </author>
    <author>
      <name>Fillet, Sandy</name>
    </author>
    <author>
      <name>Pini, Cecilia</name>
    </author>
    <author>
      <name>Molina-Henares, María Antonia</name>
    </author>
    <author>
      <name>Lacal, Jesús</name>
    </author>
    <author>
      <name>Busch, Andreas</name>
    </author>
    <author>
      <name>Silva-Jiménez, Hortencia</name>
    </author>
    <author>
      <name>Rodríguez, Sara</name>
    </author>
    <author>
      <name>Molina, Lázaro</name>
    </author>
    <author>
      <name>Bursakov, Sergey A.</name>
    </author>
    <author>
      <name>Roca, Amalia</name>
    </author>
    <author>
      <name>Segura, Ana</name>
    </author>
    <id>https://hdl.handle.net/11000/39315</id>
    <updated>2026-02-14T02:07:05Z</updated>
    <published>2026-02-13T19:14:44Z</published>
    <summary type="text">Título : 8.3 Molecular Responses to Solvent Stress: Strategies for Living in Unpalatable Substrates
Autor : Ramos, Juan Luis; Daniels, Craig; Krell, Tino; Duque, Estrella; Godoy, Patricia; de la Torre, Jesús; Fernández-Escamilla, Ana Mª; Daddaoua, Abdelali; Navarro-Avilés, Gloria; Fillet, Sandy; Pini, Cecilia; Molina-Henares, María Antonia; Lacal, Jesús; Busch, Andreas; Silva-Jiménez, Hortencia; Rodríguez, Sara; Molina, Lázaro; Bursakov, Sergey A.; Roca, Amalia; Segura, Ana
Resumen : This review article covers some general conclusions reached in research studies with respect to&#xD;
a number of solvent-tolerant Pseudomonas strains. The seminal observation was performed by&#xD;
Inoue and Korikoshi 1989 when they described in Nature a bacterium, belonging to the genus&#xD;
Pseudomonas, which was able to thrive in the presence of high concentrations of toluene. This&#xD;
property of extreme tolerance to solvents makes this Pseudomonas strain the first extremophile&#xD;
identified as able to survive in the presence of highly toxic solvents. Following this seminal&#xD;
observation, other solvent-tolerant strains, such as Pseudomonas putida DOT-T1E, S12, GM1,&#xD;
and MTB6, were described as able to grow in the presence of highly toxic solvents such as&#xD;
p-xylene (log Pow 3.15), styrene (log Pow 3.0), octanol (log Pow 2.92), and toluene (log Pow 2.69)&#xD;
(Aono et al. 1992; Cruden et al. 1992; Huertas et al. 2000; Isken and de Bont 1996; Kim et al.&#xD;
1998; Ramos et al. 1995; Weber et al. 1994). These microbes can reach high cell densities in&#xD;
culture medium in the presence of 0.3% (v/v) of the mentioned solvents, a concentration that&#xD;
kills most of the microbes we work with in our laboratories. This solvent-tolerant trait allows us&#xD;
to consider this set of Pseudomonas strains as extremophiles. Normally solvent toxicity is due to&#xD;
these chemicals dissolving in the cell membranes, disorganizing them and altering the electron&#xD;
flow. They also prevent ATP synthesis and irrevocably provoke cell death. Currently, there is an&#xD;
inherent interest in deciphering the basis for survival and growth of extremophile microbes in&#xD;
such harsh conditions, particularly for the exploitation of these microbes in the bioremediation&#xD;
of heavily-polluted sites and in the biotransformation of water-insoluble compounds into&#xD;
added-value products. The growing interest in biodegradation derives from the fact that many&#xD;
pollutants are toxic above a certain threshold, killing many living organisms. The use of&#xD;
solvent-tolerant microorganisms, provided with an arsenal of enzymes to deal with pollutants,&#xD;
represents a powerful tool for in situ pollutant removal. In the case of biotransformation, many&#xD;
substrates of interest are poorly soluble in water and the use of a double-phase system, made of&#xD;
water and an organic solvent for the production of high added-value chemicals is of great&#xD;
interest in green chemistry. Among some examples we can cite the use of solvent-tolerant&#xD;
microorganisms to produce catechols or to carry out biotransformation of aromatic hydrocarbons&#xD;
including nitro substituted ones (Ju and Parales 2006; Neumann et al. 2005, 2006;&#xD;
Ramos-Gonza´lez et al. 2003; Ruhl et al. 2009; Rojas et al. 2004; Verhoef et al. 2009; Wierckx&#xD;
et al. 2005).
Notas: Editor: Koki Horikoshi</summary>
    <dc:date>2026-02-13T19:14:44Z</dc:date>
  </entry>
  <entry>
    <title>Thermodynamic analysis of helix-engineered forms of the activation domain of human procarboxypeptidase A2</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39314" />
    <author>
      <name>Fernández-Escamilla, Ana Mª</name>
    </author>
    <author>
      <name>Villegas, Virtudes</name>
    </author>
    <author>
      <name>Martínez, José C.</name>
    </author>
    <author>
      <name>van Nuland, Nico A. J.</name>
    </author>
    <author>
      <name>Conejero-Lara, Francisco</name>
    </author>
    <author>
      <name>Avilés, Francisco X.</name>
    </author>
    <author>
      <name>Serrano, Luis</name>
    </author>
    <author>
      <name>Filimonov, Vladimir V.</name>
    </author>
    <author>
      <name>Mateo, Pedro L.</name>
    </author>
    <id>https://hdl.handle.net/11000/39314</id>
    <updated>2026-02-14T02:07:07Z</updated>
    <published>2026-02-13T18:58:21Z</published>
    <summary type="text">Título : Thermodynamic analysis of helix-engineered forms of the activation domain of human procarboxypeptidase A2
Autor : Fernández-Escamilla, Ana Mª; Villegas, Virtudes; Martínez, José C.; van Nuland, Nico A. J.; Conejero-Lara, Francisco; Avilés, Francisco X.; Serrano, Luis; Filimonov, Vladimir V.; Mateo, Pedro L.
Resumen : Thermodynamic characterization of the activation domain of human procarboxypeptidase A2, ADA2h, and its&#xD;
helix-engineered mutants was carried out by differential scanning calorimetry. The mutants were engineered by&#xD;
changing residues in the exposed face of the two a helices in order to increase their stability. At neutral and&#xD;
alkaline pH the three mutants, a-helix 1 (M1), a-helix 2 (M2) and a-helix 1 and a-helix 2 (DM), were more&#xD;
stable than the wild-type domain, in the order DM, M2, M1 and wild-type. Under these conditions the CD and&#xD;
NMR spectra of all the variants are very similar, indicating that this increase in stability is not the result of gross&#xD;
structural changes. Calorimetric analysis shows that the stabilizing effect of mutating the water-exposed surfaces&#xD;
of the helices seems to be mainly entropic, because the mutations do not change the enthalpy or the increase in&#xD;
heat capacity of denaturation. The unfolding behavior of all variants changes under acidic conditions: whereas&#xD;
wild-type and M1 have a strong tendency to aggregate, giving rise to a b conformation upon unfolding, M2 and&#xD;
DM unfold reversibly, M2 being more stable than DM. CD and NMR experiments at pH 3.0 suggest that a region&#xD;
involving residues of the second and third b strands as well as part of a-helix 1 changes its conformation. It&#xD;
seems that the enhanced stability of the altered conformation of M2 and DM reduces the aggregation tendency of&#xD;
ADA2h at acidic pH.</summary>
    <dc:date>2026-02-13T18:58:21Z</dc:date>
  </entry>
  <entry>
    <title>West Nile virus unmasked: from gene variability to future challenges</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39313" />
    <author>
      <name>Prieto-Vega, Samuel</name>
    </author>
    <author>
      <name>Berzal-Herranz, Alfredo</name>
    </author>
    <author>
      <name>Garrido, Juan José</name>
    </author>
    <author>
      <name>Arias, Armando</name>
    </author>
    <author>
      <name>Grande-Pérez, Ana</name>
    </author>
    <author>
      <name>Fernández-Escamilla, Ana Mª</name>
    </author>
    <author>
      <name>Montoya, María</name>
    </author>
    <id>https://hdl.handle.net/11000/39313</id>
    <updated>2026-02-14T02:07:07Z</updated>
    <published>2026-02-13T18:43:43Z</published>
    <summary type="text">Título : West Nile virus unmasked: from gene variability to future challenges
Autor : Prieto-Vega, Samuel; Berzal-Herranz, Alfredo; Garrido, Juan José; Arias, Armando; Grande-Pérez, Ana; Fernández-Escamilla, Ana Mª; Montoya, María
Resumen : West Nile virus (WNV) is a mosquito-borne orthoflavivirus with a complex&#xD;
transmission cycle involving avian reservoirs and mosquito vectors. Although&#xD;
no precise global infection figure exists, conservative estimates based on&#xD;
seroprevalence data suggest between 4 and 16 million infections annually.&#xD;
With an approximate mortality rate of 6–7% among reported cases, WNV&#xD;
poses a significant public health concern across continents. This review&#xD;
provides a comprehensive overview of WNV molecular biology, including&#xD;
genome organization, protein maturation, replication mechanisms, the&#xD;
functional roles of untranslated regions (UTRs) and post-translational&#xD;
modifications in viral adaptation. Particular attention is given to intrahost&#xD;
genetic variability and the quasispecies nature of WNV as key drivers of&#xD;
immune evasion and viral evolution. The ecological and epidemiological&#xD;
dynamics of WNV are also discussed in the context of climate change and its&#xD;
impact on vector distribution and global viral spread. Additionally, the review&#xD;
details clinical manifestations, pathogenesis, diagnostic tools, and current&#xD;
therapeutic strategies. Emerging approaches for prevention and control are&#xD;
explored, including entomological surveillance, vaccine development, and&#xD;
novel antiviral candidates such as targeted peptides, antibodies and lethal&#xD;
mutagenesis. Given the pressing challenges associated with WNV, this review&#xD;
underscores the importance of integrated One Health surveillance systems and&#xD;
accelerated vaccine development to mitigate future outbreaks, highlighting the&#xD;
intersection of virology, immunology, ecology, and global health.</summary>
    <dc:date>2026-02-13T18:43:43Z</dc:date>
  </entry>
  <entry>
    <title>FleQ of Pseudomonas putida KT2440 is a multimeric cyclic diguanylate&#xD;
binding protein that differentially regulates expression of biofilm matrix&#xD;
components</title>
    <link rel="alternate" href="https://hdl.handle.net/11000/39312" />
    <author>
      <name>Molina-Henares, María Antonia</name>
    </author>
    <author>
      <name>Ramos-González, María Isabel</name>
    </author>
    <author>
      <name>Daddaoua, Abdelali</name>
    </author>
    <author>
      <name>Fernández-Escamilla, Ana Mª</name>
    </author>
    <author>
      <name>Espinosa-Urgel, Manuel</name>
    </author>
    <id>https://hdl.handle.net/11000/39312</id>
    <updated>2026-02-14T02:07:05Z</updated>
    <published>2026-02-13T18:35:09Z</published>
    <summary type="text">Título : FleQ of Pseudomonas putida KT2440 is a multimeric cyclic diguanylate&#xD;
binding protein that differentially regulates expression of biofilm matrix&#xD;
components
Autor : Molina-Henares, María Antonia; Ramos-González, María Isabel; Daddaoua, Abdelali; Fernández-Escamilla, Ana Mª; Espinosa-Urgel, Manuel
Resumen : The intracellular signal molecule cyclic di-GMP (c-di-GMP) is an important element in regulation of biofilm formation by bacteria. In&#xD;
Pseudomonas aeruginosa, FleQ functions as a c-di-GMP-dependent transcriptional regulator of expression of flagellar genes and the exopolysaccharide&#xD;
(EPS) Pel, a component of the biofilm extracellular matrix. In the plant-beneficial bacterium Pseudomonas putida KT2440, a&#xD;
mutation in fleQ reduces biofilm formation and colonization of plant surfaces. Using isothermal titration calorimetry and electrophoretic&#xD;
mobility shift assays, we show in this work that FleQ of P. putida interacts with c-di-GMP and directly binds the promoter regions of flagellar&#xD;
and EPS genes. Data obtained by analytical gel filtration and ultracentrifugation indicate that FleQ is in multiple oligomeric states in solution&#xD;
(dimers, tetramers and hexamers), which do not show altered equilibrium in the presence of c-di-GMP. DNA binding is independent of c-diGMP,&#xD;
although it is favored by the second messenger in the case of the promoter of the operon responsible for synthesis of the species-specific EPS&#xD;
Pea. Analysis of expression using transcriptional fusions showed an influence of FleQ upon two of the four EPS operons under regular growth&#xD;
conditions. Finally, a consensus sequence for promoter recognition by FleQ in P. putida is also proposed.</summary>
    <dc:date>2026-02-13T18:35:09Z</dc:date>
  </entry>
</feed>

